Business Today
Loading...

Pfizer, Indian govt in discussion to expedite approval for COVID-19 vaccine: Albert Bourla

Unfortunately, our vaccine is not registered in India although our application was submitted months ago, Pfizer CEO Albert Bourla said

twitter-logoReuters | May 3, 2021 | Updated 14:37 IST
Pfizer, Indian govt in discussion to expedite approval for COVID-19 vaccine: Albert Bourla

Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.

"Unfortunately, our vaccine is not registered in India although our application was submitted months ago," he said.

"We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country."

Also read: 'Get vaccinated': Today's Google Doodle urges people to take COVID-19 vaccine

Also read: 'Vaccine shortage may continue till July,' says Serum CEO Adar Poonawalla

  • Print
  • COMMENT
BT-Story-Page-B.gif
A    A   A
close